Upload Image (Max 20MB per Image)
CardioKinetix has started enrolling patients for its PARACHUTE III, a post-market safety surveillance trial, in Germany. The dual-arm, multi-center, open-label trial, which will enroll up to 100 ischemic heart failure patients, is ...
Tags: CardioKinetix, PARACHUTE III, ischemic heart failure